Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Gu, Liying ^a,b   Dai, Lan ^a,b   Cao, Cong ^c   Zhu, Jing ^a,b   Ding, Chuanwei ^a,b   Xu, Hai Bo ^d   Qiu, Lihua ^a,b   Di, Wen ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Key Laboratory of Gynecologic Oncology   (China)

^c THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN FN14; PROTEIN TWEAK; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE ACTIVATION; OVARY CARCINOMA; OVARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TUMOR GROWTH;

CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL2; COCULTURE TECHNIQUES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; OVARIAN NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 84874618380     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057436     Document Type: Article

References (35)

1. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, et al. (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272: 32401-32410.
2. Kaptein A, Jansen M, Dilaver G, Kitson J, Dash L, et al. (2000) Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3). FEBS Lett 485: 135-141.
3. Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, et al. (2002) Multiple pathways of TWEAK-induced cell death. J Immunol 168: 734-743.
4. Winkles JA, (2008) The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7: 411-425.
5. Desplat-Jego S, Varriale S, Creidy R, Terra R, Bernard D, et al. (2002) TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol 133: 116-123.
6. Kawakita T, Shiraki K, Yamanaka Y, Yamaguchi Y, Saitou Y, et al. (2004) Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis. Biochem Biophys Res Commun 318: 726-733.
7. Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T, (2003) TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor. J Biol Chem 278: 32317-32323.
8. Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, et al. (2003) Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol 170: 341-348.
9. Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, et al. (1999) TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 274: 8455-8459.
10. Kawakita T, Shiraki K, Yamanaka Y, Yamaguchi Y, Saitou Y, et al. (2005) Functional expression of TWEAK in human colonic adenocarcinoma cells. Int J Oncol 26: 87-93.
11. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, et al. (2004) Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15: 2523-2536.
12. Ho DH, Vu H, Brown SA, Donohue PJ, Hanscom HN, et al. (2004) Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice. Cancer Res 64: 8968-8972.
13. Tran NL, McDonough WS, Donohue PJ, Winkles JA, Berens TJ, et al. (2003) The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. Am J Pathol 162: 1313-1321.
14. Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, et al. (2001) A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15: 837-846.
15. Michaelson JS, Cho S, Browning B, Zheng TS, Lincecum JM, et al. (2005) Tweak induces mammary epithelial branching morphogenesis. Oncogene 24: 2613-2624.
16. Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, et al. (2000) The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol 156: 1253-1261.
17. Winkles JA, Tran NL, Berens ME, (2006) TWEAK and Fn14: new molecular targets for cancer therapy? Cancer Lett 235: 11-17.
18. Zou H, Wang D, Gan X, Jiang L, Chen C,et al. (2011) Low TWEAK expression is correlated to the progression of squamous cervical carcinoma. Gynecol Oncol.
19. Lin BR, Huang MT, Chen ST, Jeng YM, Li YJ,et al. (2011) Prognostic Significance of TWEAK Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion. Ann Surg Oncol.
20. Wang D, Fung JN, Tuo Y, Hu L, Chen C (2010) TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway. Cancer Lett.
21. Kaduka Y, Takeda K, Nakayama M, Kinoshita K, Yagita H, et al. (2005) TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage. Biochem Biophys Res Commun 2548 331: 384-390.
22. Nakayama M, Kayagaki N, Yamaguchi N, Okumura K, Yagita H, (2000) Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity. J Exp Med 192: 1373-1380.
23. Dai L, Gu L, Ding C, Qiu L, Di W, (2009) TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression. Cancer Lett 283: 159-167.
24. Shenhua X, Lijuan Q, Hanzhou N, Xinghao N, Chihong Z,et al. (1999 no full artical) Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization. J Exp Clin Cancer Res 18: 233-239.
25. Ma S, Yang Y, Wang C, Hui N, Gu L, et al. (2009) Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathway. J Biol Chem 5328 284: 24773-24782.
26. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH, (2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5: e8668.
27. Zimmermann M, Koreck A, Meyer N, Basinski T, Meiler F,et al. (2011) TNF-like weak inducer of apoptosis (TWEAK) and TNF-alpha cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol 127: 200-207, 207 e201-210.
28. Wicovsky A, Salzmann S, Roos C, Ehrenschwender M, Rosenthal T, et al. (2009) TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling. Cell Death Differ 16: 1445-1459.
29. Diessenbacher P, Hupe M, Sprick MR, Kerstan A, Geserick P, et al. (2008) NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2. J Invest Dermatol 128: 1134-1147.
30. Ajuebor MN, Flower RJ, Hannon R, Christie M, Bowers K, et al. (1998) Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol 63: 108-116.
31. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, et al. (2001) Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 194: 1361-1373.
32. Kawakita T, Shiraki K, Yamanaka Y, Yamaguchi Y, Saitou Y, et al. (2005) Functional expression of TWEAK in human colonic adenocarcinoma cells. Int J Oncol 26: 87-93.
33. Wilson CA, Browning JL, (2002) Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 9: 1321-1333.
34. Schneider P, Schwenzer R, Haas E, Muhlenbeck F, Schubert G, et al. (1999) TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol 29: 1785-1792.
35. Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, et al. (2005) TWEAK attenuates the transition from innate to adaptive immunity. Cell 123: 931-944.